Bangkok Genomics Innovation PCLBKK:BKGI +3.96%45 Interest Coverage is 80.75 as of Dec. 2025, which is 121% above its 10-year median of 36.51. GuruFocus rates BKK:BKGI with a GF Score™ of 45/100. The stock has 12 warning signs investors should review. Among 94 Medical Diagnostics & Research companies, Bangkok Genomics Innovation PCL ranks better than 72.34% on this metric.
Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's
Operating Income
by its Interest Expense. Bangkok Genomics Innovation PCL's
Operating Income
for the
three
months ended in Dec. 2025 was ฿28.7 Mil. Bangkok Genomics Innovation PCL's Interest Expense for the
three
months ended in Dec. 2025 was ฿-0.4 Mil.
Bangkok Genomics Innovation PCL's interest coverage for the quarter that ended in Dec. 2025 was 80.75.
The higher the ratio, the stronger the company's financial strength is.
The historical rank and industry rank for Bangkok Genomics Innovation PCL's Interest Coverage or its related term are showing as below:
BKK:BKGI'
s Interest Coverage Range Over the Past 10 Years
Min: 16.37 Med: 36.51 Max: 149.15
Current: 34.41
BKK:BKGI's Interest Coverage is ranked better than 72.34% of 94
companies
in the Medical Diagnostics & Research industry
Industry Median: 9.155
vs BKK:BKGI: 34.41
Ben Graham requires that a company has a minimum interest coverage of 5 with the companies he invested. If the interest coverage is less than 2, the company is burdened by debt. Any business slow or recession may drag the company into a situation where it cannot pay the interest on its debt.
Interest Coverage is an important factor when GuruFocus ranks a company's overage Financial Strength .
Bangkok Genomics Innovation PCL Interest Coverage Related Terms
Bangkok Genomics Innovation PCL Interest Coverage Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Note: For Interest Coverage, "No debt" indicates no long-term debt. An indication of "No Debt" does not necessarily mean that the company has no long-term debt obligations; it could be due to missing data in the quarterly or annual report. Use caution when interpreting this information.
BKK:BKGI vs TMO, DHR, IDXX: Interest Coverage Comparison
For the Diagnostics & Research subindustry, Bangkok Genomics Innovation PCL's Interest Coverage, along with its competitors' market caps and Interest Coverage data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Bangkok Genomics Innovation PCL Interest Coverage vs Medical Diagnostics & Research Industry
For the Medical Diagnostics & Research industry and Healthcare sector, Bangkok Genomics Innovation PCL's Interest Coverage distribution charts can be found below:
* The bar in red indicates where Bangkok Genomics Innovation PCL's Interest Coverage falls into.
Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's Operating Income (EBIT) by its Interest Expense:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Bangkok Genomics Innovation PCL (BKK:BKGI) has a Interest Coverage of 80.75 as of Dec. 2025. Interest Coverage measures a company's capability to pay interest expenses on its debt. View historical data on Bangkok Genomics Innovation PCL and its competitors. This is 121% above median its historical median of 36.51. Over the past decade, Bangkok Genomics Innovation PCL's Interest Coverage has ranged from 16.37 to 149.15. According to the industry distribution chart, Bangkok Genomics Innovation PCL ranks #26 out of 94 companies in the Medical Diagnostics & Research industry, placing it in the top 27.7%.
Is Bangkok Genomics Innovation PCL's Interest Coverage too high?
Bangkok Genomics Innovation PCL's current Interest Coverage of 80.75 is 121% above median its 10-year median of 36.51. Over the past 10 years, this metric has ranged from a low of 16.37 to a high of 149.15. The Medical Diagnostics & Research industry median Interest Coverage is 9.16. Bangkok Genomics Innovation PCL's value of 80.75 is 782% above this industry median. Based on the distribution chart, Bangkok Genomics Innovation PCL ranks #26 out of 94 companies in the Medical Diagnostics & Research industry, which is above the industry midpoint. Overall, Bangkok Genomics Innovation PCL has a GF Score™ of 45/100, reflecting its overall financial health beyond just this single metric.
How does Bangkok Genomics Innovation PCL's Interest Coverage compare to TMO and DHR?
According to the Medical Diagnostics & Research industry distribution chart, Bangkok Genomics Innovation PCL ranks #26 out of 94 companies for Interest Coverage. This puts Bangkok Genomics Innovation PCL in the upper half of its industry. The industry median Interest Coverage is 9.16. Bangkok Genomics Innovation PCL's value of 80.75 is 782% above this benchmark. Historically, Bangkok Genomics Innovation PCL's own Interest Coverage has ranged from 16.37 to 149.15 over the past decade. While the company's 10-year median is 36.51 vs. the industry median of 9.16, Bangkok Genomics Innovation PCL has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Interest Coverage for a Medical Diagnostics & Research company?
The median Interest Coverage among Medical Diagnostics & Research companies is 9.16, based on 94 companies in the industry. Companies in the top quartile (top 25%) have a Interest Coverage significantly above this median, while those in the bottom quartile fall well below. However, Interest Coverage should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Bangkok Genomics Innovation PCL's current Interest Coverage of 80.75 is 782% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Interest Coverage mean?
A high Interest Coverage can signal that a stock is expensive relative to its fundamentals. Interest Coverage measures a company's capability to pay interest expenses on its debt. View historical data on Bangkok Genomics Innovation PCL and its competitors. For the Medical Diagnostics & Research industry, the median Interest Coverage is 9.16 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Bangkok Genomics Innovation PCL's current Interest Coverage is 80.75, which is 121% above median its own 10-year median of 36.51. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Bangkok Genomics Innovation PCL stock overvalued right now?
Bangkok Genomics Innovation PCL (BKK:BKGI) has a current Interest Coverage of 80.75. The current Interest Coverage is 80.75, which is 121% above median its 10-year median of 36.51 and 782% above the Medical Diagnostics & Research industry median of 9.16. Bangkok Genomics Innovation PCL's overall GF Score™ is 45/100 with 12 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Interest Coverage calculated?
Interest Coverage is calculated from a company's financial statements. For Bangkok Genomics Innovation PCL (BKK:BKGI), the current Interest Coverage is 80.75 as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Bangkok Genomics Innovation PCL Business Description
Bangkok Genomics Innovation PCL operate a laboratory and provide medical analysis services. Its services includes Screening for genetic abnormalities in reproductive health (Reproductive Health Testing Services),Infectious Disease Analysis Product Group (Infectious - Related Testing Services), Other screening product groups (Other Testing Services), providing technology services (Tech Solution Services), and Sales of other medical products Related (Medical - Related Products). Its segments include Sale of laboratory reagents and related products; Testing and analysis services, which derives maximum revenue; and Sale and advanced therapy medicinal product.
45GF Score
Get the complete analysis for BKK:BKGI
Interest Coverage is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
BKK:BKGI has been successfully added to your 
